The Rundown: ExL’s Blog
Viewing 51 to 60 of 115 records.
7th CROWN Congress in Applied Clinical Trials’ Interview With CQI Consulting President
Friday November 3rd, 2017
Thank you to Applied Clinical Trials for mentioning our 7th CROWN Congress in their interview with previous CROWN Congress speaker Arti Bajpai, President of Compliance and Quality Integration (CQI) Consulting. ExL’s 7th CROWN Congress is occurring on January 23-25, 2018 in Philadelphia. In this new interview, Bajpai describes Quality Management Systems (QMS) and how it connects to Risk-Based Monitoring (RBM).
“A simple way to think of QMS is the connectivity and flow from internal strategy supported by robust processes, tools, and qualified…
JUST ANNOUNCED: The 9th Annual Proactive GCP Compliance Conference, March 2018 in Philly!
Wednesday November 1st, 2017
Everyone at ExL Events is excited to announce that our 9th Annual Proactive GCP Compliance Conference will take place on March 19–21 at the Sheraton Philadelphia University City Hotel. Now in its ninth year, ExL’s Proactive GCP Compliance conference continues to act as the annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how to effectively build quality risk management approaches into your clinical operations to optimize research, maintain GCP compliance, contain costs and ensure patient safety.
Expert Insights: Q&A With Patient Access Leader, Melissa L. Paige
Friday October 27th, 2017
ExL’s Value-Based Strategies for Reimbursement and Formulary Success Conference Producer, Mercy Lister, had the opportunity to sit down and discuss some of the issues and challenges facing the industry with the event’s chair, Melissa L. Paige, Oncology Patient Access Principal Coordination at the University of Virginia Health System, NCI-Designated Emily Couric Clinical Cancer Center. See excerpts from the Q&A session below.
Q: How do you collaborate with payers and pharma to get access to the right product at the right time for the right patient?
A: Prior to any product launch, we seek…
JUST ANNOUNCED: 7th Digital Marketing for Medical Devices West in San Francisco
Monday October 23rd, 2017
The entire ExL Events team is excited to announce that the 7th Digital Marketing for Medical Devices West conference is taking place April 23–25, 2018 in San Francisco!
The 7th Digital Marketing for Medical Devices West conference is built on a foundation providing device marketers with seven years of informative, relevant content and is attended by marketers representing device organizations of all sizes. This conference is designed to provide you with in-depth, tactical presentations that supply you with a roadmap for implementing similar programming at your organization and insights into some of the leading marketing trends impacting the industry…
100+ Companies Represented at the 13th Pharma Meeting Pros Summit, Nov. 6–7 in Philly
Friday October 20th, 2017
The 13th Pharmaceutical Meeting Professionals Summit is coming up in just a few weeks on November 6–7 in Philadelphia. Over 60% of the current audience represents meeting planners from well over 100 different companies in various industries. Check out this experienced group ready to engage, collaborate, and innovate to optimize medical meeting management.
ALTOUR Meetings & Incentives
American Audio Visual
American Express Meetings & Events
Andavo Meetings & Incentives
Ashfield Meetings & Events
Beverly Hills Conference & Visitors Bureau
Big Sky Resort
Boehringer Ingelheim Pharmaceuticals
Cheshire Audio Visual
Cornerstone Meetings & Events
Game-Changers for Expedited Drug Development at the Innovative Regulatory Pathways Summit
Friday October 13th, 2017
The Innovative Regulatory Pathways Summit, taking place January 29–30 in Arlington, VA, is the only regulatory affairs conference dedicated to global strategies for expediting drug development.
Download our brochure here to review the sessions dedicated to how breakthrough therapy designations fit into global development pipelines.
Receiving a breakthrough therapy designation has a huge impact on clinical development, which is why Joseph A. Sliman, M.D., MPH, Chief Medical Officer, at Synthetic Biologics, will discuss the implications of receiving a breakthrough therapy designation on clinical trial design for narrow populations.
A manufacturing plan that is harmonized with expedited clinical develop…
Exclusive Q&A: Susan B. Levy Consulting’s Founder and Principal Discusses Rx-to-OTC Switch
Tuesday October 10th, 2017
Before she takes that podium at our 4th Rx-to-OTC Switch Summit, Susan B. Levy Consulting’s Founder and Principal, Susan Levy, sat down with ExL to discuss the OTC market and pre-launch preparation. Take a look here:
You’ve been involved in ExL Events’ Rx-to-OTC Summit since 2014 — what has changed since then and what brings you back?
Since 2014, we’ve seen additional switches in existing OTC categories, including Flonase, Nexium, Rhinocort, and Xyzal. Some of these switches have been more successful than others. We’ve also seen two Advisory Committee Meetings. Singulair failed to…
Industry Leaders From Pfizer, Merck and Pacira Share Insights at the Value-Based Reimbursement Event!
Thursday October 5th, 2017
The methodical challenges faced by market access professionals can vastly differ by therapeutic area, size of the organization, and the number of resources available to them. Cookie-cutter solutions cannot address the unique challenges faced by a company. It is critical that the education available to market access professionals meets the varying needs of the industry. Don’t worry — leaders from Pfizer, Merck, Pacira and more share insights at our Value-Based Reimbursement event.
The speaking faculty at ExL’s Value-Based Strategies for Reimbursement and Formulary Success conference consists of executives from pharmaceutical…
Non-Profit Representation at ExL’s Premier Co-Located Event Series
Tuesday October 3rd, 2017
ExL’s premier co-located event series, taking place October 26–27 in Boston, features three conferences, 50+ speakers, and two days of shared networking with 150+ industry executives. These three conferences will bring together experts from nonprofits, NGOs, academia, pharmaceutical companies and biotechs to discuss the balance between social equity and business goals.
The Non-Profit/NGO/Academic rate is 40% off the standard registration price for all of the below conferences…
* To receive this discount, please use Discount Code 2017NP
View the agenda…
Neglected Tropical Diseases Forum: GSK, Merck, and More Discuss Strategic Partnerships in Global Health Programs
Friday September 29th, 2017
The Neglected Tropical Diseases Forum, taking place on October 26–27, 2017 in Boston, is the premier event for building strategic partnerships to support global health programs across the biomedical landscape. Attendees will hear case studies about strategies that support sustained funding and help overcome clinical development and regulatory challenges associated with NTD treatments and diagnostics.
Review all of the session topics and presentations in our agenda here.
Michael Eichberg, Director, Strategic Alliances, Merck, will be discussing experiences with synergistic partnerships to combat the Ebola outbreak.
Shelly O’Donovan, Former…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs